China Resources Double-Crane Pharmaceutical Co.,Ltd.

SHSE:600062 Stock Report

Market Cap: CN¥22.2b

China Resources Double-Crane PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 5/6

China Resources Double-Crane PharmaceuticalLtd has a total shareholder equity of CN¥12.2B and total debt of CN¥259.7M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are CN¥15.7B and CN¥3.5B respectively. China Resources Double-Crane PharmaceuticalLtd's EBIT is CN¥1.5B making its interest coverage ratio -38.5. It has cash and short-term investments of CN¥3.6B.

Key information

2.1%

Debt to equity ratio

CN¥259.67m

Debt

Interest coverage ratio-38.5x
CashCN¥3.65b
EquityCN¥12.20b
Total liabilitiesCN¥3.48b
Total assetsCN¥15.68b

Recent financial health updates

No updates

Recent updates

China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 24
China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel

Mar 02
Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel

Financial Position Analysis

Short Term Liabilities: 600062's short term assets (CN¥7.9B) exceed its short term liabilities (CN¥3.0B).

Long Term Liabilities: 600062's short term assets (CN¥7.9B) exceed its long term liabilities (CN¥458.7M).


Debt to Equity History and Analysis

Debt Level: 600062 has more cash than its total debt.

Reducing Debt: 600062's debt to equity ratio has increased from 1.1% to 2.1% over the past 5 years.

Debt Coverage: 600062's debt is well covered by operating cash flow (697.9%).

Interest Coverage: 600062 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.